Jci_page_head_homepage_01 Jci_page_head_homepage_02
Rajesh K. Thimmulappa, Hannah Lee, Tirumalai Rangasamy, Sekhar P. Reddy, Masayuki Yamamoto, Thomas W. Kensler, Shyam Biswal
Published in Volume 116, Issue 4
J Clin Invest. 2006; 116(4):984–995 doi:10.1172/JCI25790
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6
LPS induced greater NF-κB activation in lungs of Nrf2-deficient mice.

(A) Lung nuclear extracts from Nrf2–/– and Nrf2+/+ mice were assayed for NF-κB DNA-binding by EMSA 30 minutes after instillation of LPS (10 μg per mouse). The major NF-κB bands contained p65 and p55 subunits, as determined by the supershift obtained by p65 and p50 antibody. Lanes: 1, vehicle, Nrf2+/+; 2, LPS, Nrf2+/+; 3, vehicle, Nrf2–/–; 4, LPS, Nrf2–/–; 5, LPS, Nrf2+/+ with p65 antibody, 6, LPS, Nrf2+/+ with p50 antibody. SS, supershift. (B) Quantification of NF-κB DNA-binding was performed by densitometric analysis. All values are mean α SEM obtained from 3 animals per treatment group and are represented as relative to respective vehicle control. (C) Nuclear accumulation of p65 by Western blot in the nuclear extracts derived from lungs of Nrf2+/+ and Nrf2–/– mice 30 minutes after instillation of LPS (10 μg/mouse). Lamin B1 was used as loading control. (D) Densitometric analysis of Western blot of RelA relative to wild-type vehicle control. All values are mean α SEM; n = 3. *Differs from vehicle control of the same genotype. Differs from LPS-treat wild-type mice. P < 0.05.